The slip
PARKINSON RECEIPTno. 15665
31 Oct 2026, 00:51 UTCmicroglia, braak
predictionIFNGR2 in microglia tracks Braak Lewy-body stage
registered0dc8195efbdb59bf
discovery+0.48 p=0.190 n=9
replication-0.06 p=0.877 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.48, p 0.190)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT945b2e42e0dc4e19457ef0f2…
follows 2d729a4565ed…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 15665: IFNGR2 in microglia, braak
- power
- full sample +0.17 (p 0.493, n 18), 95% CI -0.32 to +0.59. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.17 (p 0.493, n 18). does not hold up.
- composition
- microglia share of nuclei vs axis -0.11 (p 0.652); controlling for it: +0.17 (p 0.509, n 18). could be the mix.
- skeptic
- leave-one-out range +0.05 to +0.31, sign flips 0; without severely affected donors +0.17 (p 0.493, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for IFNGR2 in microglia.
case closed: nothing better to follow up.